T1	PROC 1 47	Cirugía transnasal transesfenoidal endoscópica
T2	PROC 1883 1896	procedimiento
#1	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T3	DISO 51 77	afecciones de región selar
#2	AnnotatorNotes T3	C4524211; Sellar lesion; Disease or Syndrome
T4	DISO 117 136	tumores pituitarios
#3	AnnotatorNotes T4	C0032019; Pituitary Neoplasms; Neoplastic Process
T5	PROC 140 147	cirugía
#4	AnnotatorNotes T5	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T6	PROC 154 182	tratamiento de primera línea
#5	AnnotatorNotes T6	C1708063; First line treatment; Therapeutic or Preventive Procedure
T7	PROC 213 228	microquirúrgico
#6	AnnotatorNotes T7	C0026035; Microsurgery; Therapeutic or Preventive Procedure
T8	PROC 375 386	endoscópico
#7	AnnotatorNotes T8	C0014245; Endoscopy (procedure); Diagnostic Procedure
T9	PROC 624 635	endoscópico
#8	AnnotatorNotes T9	C0014245; Endoscopy (procedure); Diagnostic Procedure
T10	DISO 645 672	lesiones de la región selar
#9	AnnotatorNotes T10	C4524211; Sellar lesion; Disease or Syndrome
T11	ANAT 660 672	región selar
#10	AnnotatorNotes T11	C4744370; Sellar Region; Body Location or Region
T12	PROC 744 766	método transesfenoidal
T13	PROC 806 837	fase I de un ensayo en 3 etapas
T14	PROC 853 888	investigación limitada tipo cohorte
T15	PROC 904 928	controlada y prospectiva
#11	AnnotatorNotes T15	C0206035; Controlled Clinical Trials, Randomized; Research Activity + C0033522; Prospective Studies; Research Activity
T16	PROC 1042 1053	endoscópico
#12	AnnotatorNotes T16	C0014245; Endoscopy (procedure); Diagnostic Procedure
T17	PROC 1069 1091	tratamiento quirúrgico
#13	AnnotatorNotes T17	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T18	PROC 1213 1224	Se operaron
#14	AnnotatorNotes T18	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T19	DISO 1247 1273	macroadenomas hipofisarios
#15	AnnotatorNotes T19	C0346308; Pituitary macroadenoma; Neoplastic Process
T20	CHEM 1295 1297	GH
#16	AnnotatorNotes T20	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T21	CHEM 1315 1318	PRL
#17	AnnotatorNotes T21	C0033371; prolactin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Hormone
T22	PROC 1379 1392	diagnosticado
#18	AnnotatorNotes T22	C0011900; Diagnosis; Diagnostic Procedure
T23	DISO 1393 1407	fístula de LCR
T24	ANAT 1404 1407	LCR
#19	AnnotatorNotes T24	C0007806; Cerebrospinal Fluid; Body Substance
T25	DISO 1445 1458	macroadenomas
#20	AnnotatorNotes T25	C0346308; Pituitary macroadenoma; Neoplastic Process
T26	PROC 1478 1492	exéresis total
#21	AnnotatorNotes T26	C0015250; Complete excision; Therapeutic or Preventive Procedure
T27	DISO 1497 1502	tumor
#22	AnnotatorNotes T27	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T28	PROC 1538 1555	exéresis subtotal
#23	AnnotatorNotes T28	C4330937; Partial Resection; Therapeutic or Preventive Procedure
T29	DISO 1560 1568	rinorrea
#24	AnnotatorNotes T29	C1260880; Rhinorrhea; Sign or Symptom
T30	DISO 1600 1614	fístula de LCR
T31	ANAT 1611 1614	LCR
#25	AnnotatorNotes T31	C0007806; Cerebrospinal Fluid; Body Substance
T32	DISO 1651 1665	complicaciones
#26	AnnotatorNotes T32	C0009566; Complication; Pathologic Function
T33	PROC 1839 1868	método transnasal endoscópico
T34	PROC 1978 2024	fase II del ensayo (aleatorizada y controlada)
#27	AnnotatorNotes T34	C0282460; Phase 2 Clinical Trials; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
T35	PROC 2144 2163	cirugía hipofisaria
#28	AnnotatorNotes T35	C2224799; pituitary surgery; Therapeutic or Preventive Procedure
T36	ANAT 65 77	región selar
#29	AnnotatorNotes T36	C4744370; Sellar Region; Body Location or Region
T37	ANAT 125 136	pituitarios
#30	AnnotatorNotes T37	C0032005; Pituitary gland; Body Part, Organ, or Organ Component
T38	ANAT 1261 1273	hipofisarios
#31	AnnotatorNotes T38	C0032005; Pituitary gland; Body Part, Organ, or Organ Component
T39	ANAT 1421 1431	piso selar
T40	ANAT 2152 2163	hipofisaria
#32	AnnotatorNotes T40	C0032005; Pituitary gland; Body Part, Organ, or Organ Component
T41	Date 247 264	En estos momentos
T42	Date 337 350	Recientemente
T44	Date 463 483	en un futuro próximo
T47	LIVB 881 888	cohorte
#33	AnnotatorNotes T47	C0599755; Cohort; Population Group
T48	LIVB 935 944	pacientes
#34	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Date 1098 1113	Agosto del 2002
T50	Date 1116 1131	Agosto del 2003
T53	LIVB 1586 1595	pacientes
#35	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Time 1745 1760	transoperatorio
#36	AnnotatorNotes T54	C0021891; Intraoperative Period; Temporal Concept | C0456904; Intraoperative; Temporal Concept
T43	Observation 1334 1345	productores
A1	Assertion T43 Negated
T45	Neg_cue 1331 1333	no
R1	Negation Arg1:T45 Arg2:T43	
T46	Spec_cue 551 558	posible
T51	CONC 588 623	abordaje transnasal transesfenoidal
A2	Assertion T51 Speculated
#37	AnnotatorNotes T51	C0521131; Transnasal approach; Spatial Concept + C0205508; Transsphenoidal approach; Spatial Concept 
R2	Speculation Arg1:T46 Arg2:T51	
T52	CONC 751 766	transesfenoidal
#38	AnnotatorNotes T52	C0521131; Transnasal approach; Spatial Concept
T55	CONC 1022 1041	abordaje transnasal
#39	AnnotatorNotes T55	C0521131; Transnasal approach; Spatial Concept
T56	CONC 9 35	transnasal transesfenoidal
#40	AnnotatorNotes T56	C0521131; Transnasal approach; Spatial Concept + C0205508; Transsphenoidal approach; Spatial Concept
T57	CONC 188 212	abordaje transesfenoidal
#41	AnnotatorNotes T57	C0205508; Transsphenoidal approach; Spatial Concept 
T58	CONC 325 335	transnasal
#42	AnnotatorNotes T58	C0521131; Transnasal approach; Spatial Concept
T59	CONC 1846 1856	transnasal
#43	AnnotatorNotes T59	C0521131; Transnasal approach; Spatial Concept
T60	CONC 355 374	abordaje transnasal
#44	AnnotatorNotes T60	C0521131; Transnasal approach; Spatial Concept
T61	CONC 299 312	vía sublabial
#45	AnnotatorNotes T61	C0442186; Sublabial approach; Spatial Concept 
T62	Spec_cue 435 442	pudiera
T63	CONC 452 462	predominar
A3	Assertion T63 Speculated
#46	AnnotatorNotes T63	C0332251; Predominate; Qualitative Concept 
R3	Speculation Arg1:T62 Arg2:T63	
R4	Overlap Arg1:T63 Arg2:T44	
R5	Overlap Arg1:T60 Arg2:T42	
A4	Assertion T9 Speculated
R6	Speculation Arg1:T46 Arg2:T9	
R7	Used_for Arg1:T56 Arg2:T1	
R8	Location_of Arg1:T36 Arg2:T3	
R9	Location_of Arg1:T37 Arg2:T4	
R10	Used_for Arg1:T57 Arg2:T5	
R11	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T7	
R12	Has_Quantifier_or_Qualifier Arg1:T60 Arg2:T8	
R13	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T9	
R14	Location_of Arg1:T11 Arg2:T10	
R15	Used_for Arg1:T52 Arg2:T12	
R16	Has_Quantifier_or_Qualifier Arg1:T55 Arg2:T16	
R18	After Arg1:T17 Arg2:T49	
R19	Used_for Arg1:T55 Arg2:T17	
R17	Before Arg1:T17 Arg2:T50	
R20	Experiences Arg1:T48 Arg2:T16	
R21	Experiences Arg1:T48 Arg2:T17	
R22	Experiences Arg1:T47 Arg2:T16	
R23	Experiences Arg1:T47 Arg2:T17	
R24	Location_of Arg1:T38 Arg2:T19	
T64	Observation 1280 1297	productores de GH
T65	Observation 1303 1318	secretor de PRL
R25	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T64	
R26	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T65	
R27	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T43	
R29	Location_of Arg1:T39 Arg2:T23	
#47	AnnotatorNotes T30	C0023182; Cerebrospinal fluid leak; Pathologic Function
R30	Experiences Arg1:T53 Arg2:T30	
#48	AnnotatorNotes T23	C0023182; Cerebrospinal fluid leak; Pathologic Function
R28	Experiences Arg1:T53 Arg2:T29	
R32	Overlap Arg1:T32 Arg2:T54	
R33	Used_for Arg1:T59 Arg2:T33	
R34	Location_of Arg1:T40 Arg2:T35	
#49	AnnotatorNotes T42	C0332185; Recent; Temporal Concept
#50	AnnotatorNotes T41	C0521116; Current (present time); Temporal Concept
#51	AnnotatorNotes T65	C1559239; Neuroendocrine Prolactin Hormone Secretion Abnormality, CTCAE; Finding (?)
A5	Experiencer T47 Patient
A6	Experiencer T48 Patient
A7	Experiencer T53 Patient
